Altamira Therapeutics · Biologic · Phase 3
DiscontinuedTherapeutic
Evidence
company
Confidence
95%
Indications
Hearing LossSensorineural Hearing LossSudden Sensorineural Hearing Loss
Population
AdultSudden / SSNHLProfound
Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.